| Literature DB >> 28471393 |
Abstract
Polyphenols are plant secondary metabolites containing antioxidant properties, which help to protect chronic diseases from free radical damage. Dietary polyphenols are the subject of enhancing scientific interest due to their possible beneficial effects on human health. In the last two decades, there has been more interest in the potential health benefits of dietary polyphenols as antioxidant. Black soybeans (Glycine max L. Merr) are merely a black variety of soybean containing a variety of phytochemicals. These phytochemicals in black soybean (BSB) are potentially effective in human health, including cancer, diabetes, cardiovascular diseases, cerebrovascular diseases, and neurodegenerative diseases. Taking into account exploratory study, the present review aims to provide up-to-date data on health benefit of BSB, which helps to explore their therapeutic values for future clinical settings. All data of in vitro and in vivo studies of BSB and its impact on human health were collected from a library database and electronic search (Science Direct, PubMed, and Google Scholar). The different pharmacological information was gathered and orchestrated in a suitable spot on the paper.Entities:
Keywords: antioxidants; black soybean; health benefits; human diseases; polyphenols
Mesh:
Substances:
Year: 2017 PMID: 28471393 PMCID: PMC5452185 DOI: 10.3390/nu9050455
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Role of polyphenols in humans.
Figure 2Anthocynins isolated from back soybean [45,46,47].
Summary of in vivo and in vitro studies of health benefit potentials of Anthocyninsrich BSB.
| Model | Anthocyanin Rich BSB | Dose and Route of Administration | Negative Control | Investigation | Results | Reference |
|---|---|---|---|---|---|---|
| Mouse | Anthocyanin | 24 mg/kg/day PO | Lipopolysaccharide | Assay of phospho-c-JNK1, IL-1β, TNF-α, transcription factor NF-κB, GFAP, Iba-1, Bax, cytosolic cytochrome C, cleaved caspase-3 and PARP-1 | Neuroprotective activity | [ |
| Obesity human | Anthocyanin-rich BSB testa extracts | 2.5 g/day PO | Obesity human | Assay of TG,LDL-C, non-HDL-C, TC/HDL-C and LDL-C/HDL-C | Anti-obesity | [ |
| Mouse | Anthocyanin-rich BSB seed coat | 60 mg/kg/PO | Collagen induced arthritis | Assay of histological inflammation, cartilage scores, oxidative stress markers, pro-inflammatory cytokines and NF-κB signaling | Anti-arthritic activity | [ |
| Apc (Min/+) mice | Anthocyanin-rich BSB seed coat | 0.2% or 0.5% /kg/PO | - | Assay of Number of intestinal tumors, and cellular expression of β-catenin | Anti-cancer activity | [ |
| Apc(Min) mouse | Cyanidin-3-glucoside | 0.03%, 0.1% or 0.3% | - | Assay of Plasma, urine and intestinal mucosaanthocyaninswere determined by HPLC, UV spectrophotometry and tandem MS | Anti-cancer activity | [ |
| Human hepatoma (HepG2) cells | BSB seed coats | 67 µg/mL | Hydrogen peroxide | Assay of ERK, intracellular total protein phosphatase activity | Anti-cancer activity | [ |
| Human brain neuroblastoma SK-N-SH cells | Cyanidin-3-O-glucoside, Delphinidin-3-O-glucoside, and petunidin-3-O-glucoside | 67 µg/mL | Hydrogen peroxide | Assay of cell viability, ROS, expression of heme oxygenase (HO)-1 ,MAP kinase, ASK1-JNK/p38 pathways by MTT assay, DCF-DA assay, RT-PCR, and Western blotting | Anti-cancer activity | [ |
| Humanhepatoma (HepG2) cells and ICR mice | BSB seed coats extracts | 25 μg/mL | Benzo[a]pyrene | Assay of cytochrome P4501A1 expression, Nrf2 to antioxidant response elements | Anti-cancer activity | [ |
| Ratpheochromocytoma (PC12 cell line) | non-anthocyanin fraction | 3, 6, 12, and 25 μg/mL | Amyloid β peptide | Assay of cellular oxidative stress by using DCF-DA, MTT, LDH, MDA level, acetylcholinesterase activity | Anti-amnesic effect | [ |
| Human lens epithelial cell line (HLE-B3) | BSB seed coats extracts | 0, 50, 100 and 200 μg/mL | Hydrogen peroxide | Assay of apoptosis by Annexin V assay and APO-BrdU TUNEL assay; Western blot and immunostaining of apoptosis-related molecules; Bcl2, Bax, p53 and caspase-3. | Anti- cataract effect | [ |
| Rat primary cortical neuron cells | BSB (cv. Cheongja 3, Glycine max (L.) MERR.) seed coat | 50 mg/mL | Glutamate | Assay of LDH, MTT, Intracellular ROS and immunofluorescence | Neuroprotective effect | [ |
| 3T3-Ll cells db/db mice | Anthocyanin cyanidin-3-glucoside | 60 mg/kg/PO | - | Assay of PPARγ and C/EBPα gene expressions, TNF-α, PGC-1α, SIRT1 and UCP-3 | Antiobesity and antidiabetic effects | [ |
| 3T3-Ll cells | Anthocyanin cyanidin-3-glucoside | 12.5 and 50 μg/mL | - | Assay of MTT, expression of the peroxisome proliferator-activated receptor γ and measurement of lipolysis | Antiobesity and antidiabetic effects | [ |
| Wistar albino rats | Anthocyanin cyanidin-3-glucoside | Anthocyanins (24 mg/kg) along with and vitC (100 mg/kg) | 10% ( | Assay of MTT, expression of GABAB1 receptor,Bax/Bcl-2 ratio, release of cytochrome C and activation of caspase-3 and caspase-9 | Neuroprotective effect | [ |
| Wistar albino rats | Anthocyanin cyanidin-3-glucoside | Anthocyanins (24 mg/kg) along with and vitamin c (100 mg/kg) | 10% ( | Assay of GABAB1 receptor, cellular levels of proapoptotic proteins such as Bax, activated caspase-3, and cleaved poly (ADP-ribose) polymerase 1 (PARP-1) intracellular free Ca (2+) level and CaMKII | Neuroprotective effect | [ |
| Wistar albino rats | Anthocyanin cyanidin-3-glucoside | Anthocyanins (24 mg/kg) along with and vitamin c (100 mg/kg) | 10% ( | Assay of expression of glutamate receptors, intracellular signaling molecules, and various synaptic, inflammatory, and apoptotic markers | Neuroprotective effect | [ |
| Mouse hippocampal cell line (HT22) and primary prenatal rat hippocampal neurons | Anthocyanin cyanidin-3-glucoside | 12.5 and 50 μg/mL | Kainic acid | intracellular Ca2+ level, ROS, AMPK, Bcl-2, cytochrome-c, and caspase-3 | Antioxidant activity | [ |
| Human | BSB seed coat | 60 mg/kg/PO | STZ | Assay of glycemic control and lipid metabolism parameters | Anti-hyperlipidemic effect | [ |
| in vitro (prostate cancer- DU-145 cells) and in vivo (in athymic nude mouse xenograft model) | Anthocyanin | 8 mg/kg | - | Assay of MTT, p53, Bax, Bcl, androgen receptor (AR), and prostate specific antigen | Anti-cancer activity | [ |
| HT22 cell lines and adult wister male rats | Anthocyanin | 0.2 mg/kg | Amyloid beta 1-42 | Assay of MTT, mitochondrial membrane potential, intracellular free Ca2+ and apoptotic cells (fluoro-jade B and TUNEL),Western blot analyses were performed | Neuroprotective effect | [ |
| Wistar albino rats | Anthocyanin | 50 mg/kg/PO | Human fibrin and thrombin solutions | Assay of Masson trichrome and transforming growth factor | Anti-inflammatory and antifibrosis effects | [ |
| In vitro | BSB seed coat | 388 mg/100 g | - | Assay of DPPH and ABTS+ | Antioxidant properties | [ |
| Wistar albino rats and rat pheochromocytoma PC12 cell line | Non-anthocyanins | 10, 20 mg/kg/PO | H2O2 and trimethyltin | Assay of MTT, LDH, AChE in vitro inhibition, Y-maze test, Passive avoidance test and MDA levels | Beneficial for neurodegenerative disorders | [ |
| Sprague-Dawley rats | BSB | 10, 20 mg/kg PO | ciprofloxacin, | Assay of prostate tissue, urine culture, and histological analysis | Anti-inflammatory and antimicrobial effects | [ |
| In vitro | Black soybean tea | 10, 20 mg/kg PO | - | Assay of DPPH, ferrous ion chelating ability and reducing power | Antioxidant activity | [ |
| In vitro | 10, 20 mg/kg PO | - | Assay of DPPH, ferrous ion chelating ability and reducing power | Antioxidant activity | [ | |
| In vitro | 20 soybean hybrids | 10, 20 mg/kg PO | - | Assay of DPPH | Antioxidant activity | [ |
| In vitro | BSB hybrids | 10, 20 mg/kg PO | - | Assay of DPPH, ferric reducing antioxidant power, oxygen radical absorbance capacity | Antioxidant activity | [ |
| In vitro | BSB hybrids | 10, 20 mg/kg PO | - | Assay of total phenolic content, total flavonoid content, condensed tannin content, monomeric anthocyanin content, DPPH free radical scavenging activity, ferric reducing antioxidant power, and oxygen radical absorbing capacity | Antioxidant activity | [ |
| In vitro | 30 BSB hybrids | 10, 20 mg/kg PO | - | Assay of total phenolic content, total flavonoid content, condensed tannin content, monomeric anthocyanin content, DPPH free radical scavenging activity, ferric reducing antioxidant power, and oxygen radical absorbing capacity | Antioxidant activity | [ |
| Male Sprague-Dawley rats | Anthocyanins | 6 mg/kg and 24 mg/kg PO | - | Assay of body weight and daily food intake, neuropeptide Y, GABAB1 receptor, protein kinase A-α, and phosphorylated cAMP-response element binding protein | Hypolipidemic and anti-obesity effects | [ |
| Wistar albino rats | BSB seed coats | 0.037%/PO | High fat diet—16% lard oil | Assay of body weight, adipose tissue weight, and serum lipids | Anti-obesity effect | [ |
| C57BL/6 mice | 0.5 and 1.0 g/kg/PO | High fat diet—16% lard oil | Assay of blood glucose, TC, leptin and measurement of epididymal, retroperitoneal, and perirenal fat pads | Anti-obesity effect | [ | |
| Male KK- | BSB seed coat extract | 22.0 g of BE/kg diet/PO | - | Assay of blood glucose, insulin, AMP-activated protein kinase, glucose transporter 4 | Anti-diabetic effects | [ |
| Gastric adenocarcinoma, ATCC CRL 1739 | Anthocyanin | 50 µg/mL | - | Assay of cell viability, ROS, Western blot analyses, RT-PCR were performed to assess gene and protein expression | Anti-oxidative, antibacterial and anti-inflammatory effects | [ |
| Immortalized epidermal keratinocyte cell line (HaCaT) and human neonatal dermal fibroblasts | Anthocyanin | 50 µg/mL | H2O2 | Assay of tissue VEGF, TSP1, CD31, NF-κB, and phosphorylation of IκBα | Wound healing properties | [ |
| Human dermal fibroblasts and keratinocytes cell lines | BSB seed coat extracts | 100 µg/mL | - | Assay of TNF-alpha, NF-kB, p65, VEGF in in fibroblasts and keratinocytes | Anti-inflammatory effects | [ |
| Wistar albino rats | BSB seed coat extracts | 50 and 100 mg/kg/PO | - | Assay of TNF-alpha, ICAM, NF-kB,cyclooxygenase-2, VEGF in in fibroblasts and keratinocytes | Anti-inflammatory properties against ischemia-reperfusion injury | [ |
| Bovine aortic endothelial cells and male Sprague-Dawley rats | Anthocyanin BSB seed coat | 25, 50 and 100 mg/kg/PO | LAD occlusion and reperfusion | Assay of MTT, Luciferase, TNF-alpha, ICAM, NF-kB, cyclooxygenase-2, vascular endothelial growth factor | Cardioprotective effect | [ |
| Murine BV2 microglial cells | Anthocyanin BSB seed coat | 100 µg/mL | Lipopolysaccharides | Assay of NO, prostaglandin E(2), and pro-inflammatory cytokines, including TNF-α IL-1β, NO synthase, cyclooxygenase-2, NF-κB, ERK, c-JNK, p38 MAP kinase, and Akt. | Anti-inflammatory and potent neurodegenerative diseases | [ |
| U2OS cells | Anthocyanin BSB seed coat | 200 μg/mL | - | Assay of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, protein kinase B and adenosyl mono-phosphate-dependent protein kinase | Anticancer effects | [ |
| Wistar albino rats | Anthocyanin | 40 or 80 mg/kg PO | Varicocele-induced rats | Histological examination and semen analysis | Anti-infertility effects | [ |
| Wistar albino rats | Anthocyanin | 40, 80, and 160 mg/kg PO | benign prostatic hyperplasia-induced rats | Assay of apoptosis in the prostates by the TUNEL assay | Anti-infertility effects | [ |
| Wistar albino rats | Anthocyanin BSB seed coat | 50 mg/kg PO | Electro-retinographic recordings and morphological analyses | Anti-blindness | [ | |
| Detroit 551 cells | fermented BSB broth | 200 μg/mL | - | Assay of DPPH radical scavenging effect, reducing power and ferrous ion chelating effect. | Antioxidant effect | [ |
| Human U87 glioma cells | Anthocyanin BSB seed coat | 100 μg/mL | - | Assay of autophagy, Atg5 expression | Anti- stroke effect | [ |
| Wistar albino rats | citric acid fermented of BSB | 10 mL/kg | Ferricnitrilotriacetate | Assay of antioxidative enzymes including catalase, glutathione peroxidase, glutathione reductase, glutathione | Anti- renal tubular oxidative damage | [ |
| In vitro | BSB fermented with either | 2, 4, 6 mL | - | Assay of ACE inhibitory activity and the reducing power of the fermented BSB | Antioxidant activity | [ |
| In vitro | solid fermentation of steamed BSB | 100 μg/mL | 4-nitroquinoline- | Assay of mutagenicity | Mutagenicity and antimutagenicity effects | [ |
| In vitro | BSB with | 100 μg/mL | water, 80% methanol, 80% ethanol, 80% acetone | Assay of DPPH radical-scavenging effect, and Fe2+-chelating activity | Antioxidant activity | [ |
| Wistar albino rats and In vitro | Anthocyanin BSB seed coat | 100 μg/mL | UVB-induced apoptotic cell death | Assay of caspase-3, Bax, NF-κB, cylooxygenase-2 | Anti-skin cancer | [ |
| In vitro | Hot water extracts of BSB | 100 μg/mL | Human adenovirus type 1 and coxsackievirus B1 | WST assay and in vitro antiviral assay | Antiviral activity | [ |
ABTS—2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid; AChE—acetyl choline esterase; ASK—1-Apoptosis signal-regulating kinase 1; BSB—Black soybeans; cAMP—cyclic adenosine mono phosphate; CD—cluster of differentiation; DCF—DA-dichlorofluorescein diacetate; DNA—Deoxy ribonucleic acid; DPPH—2,2-diphenyl-1-picrylhydrazyl; ERK—extracellular signal–regulated kinases; GABA—γ-aminobutyric acid; GFAP—Glial fibrillary acidic protein; HDL—C-high density lipoprotein cholesterol; HO—heme oxygenase; HPLC—high performance liquid chromatography; ICAM—intracellular adhesion molecule-1; IL—Interleukin; JNK—Jun N-terminal Kinase; LDH—lactate dehydrogenase; LDL-C—LDL-cholesterol; MAP kinase—mitogen-activated protein kinase; MDA—melondialdehyde; MS—mass spectroscopy; MTT—3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NF-kB—nuclear factor kappa B; NO—nitric oxide; NRF-1—Nuclear factor erythroid 2-related factor 1; PARP—Poly (ADP-ribose) polymerase; PPAR—peroxisome proliferator-activated receptors; ROS—reactive oxygen species; RT-PCR—reverse transcriptase-polymerase chain reaction; TC—total cholesterol; TG—Triglycerides; TNF—tumor necrosis factor; TSP1—thrombospondin; VCAM—vascular cell adhesion molecule-1; VEGF—Vascular endothelial growth factor; PO—per oral.